Refine
Has Fulltext
- yes (19)
Is part of the Bibliography
- yes (19)
Year of publication
Document Type
- Journal article (19) (remove)
Language
- English (19)
Keywords
- B cells (2)
- BMP (2)
- BMP-2 (2)
- Bone morphogenetic protein-2 (2)
- bone regeneration (2)
- gene expression (2)
- growth factor beta (2)
- multiple myeloma (2)
- subcutaneous animal model (2)
- tissue engineering (2)
- Apoptosis (1)
- B cell receptors (1)
- BMP-2 delivery (1)
- Biocompatibility (1)
- Biodegradable polymer scaffolds (1)
- Bone tissue engineering (1)
- CYR61 (1)
- Cancer (1)
- GDF-5 (1)
- Growth; BMP-2 (1)
- In-vitro (1)
- Mandibular continuity defects (1)
- Marrow stromal cells (1)
- Mechanisms (1)
- Mesenchymal transition (1)
- Microenvironment (1)
- Myofibroblast differentiation (1)
- Oral squamous cell carcinoma (1)
- Proliferation (1)
- R57A (1)
- Receptor (1)
- Sinus floor augmentation (1)
- Smooth-muscle-cells (1)
- Squamous-cell carcinoma (1)
- TGF-beta (1)
- TGFβ/BMP signaling (1)
- Tumorigenicity (1)
- animal model (1)
- antagonist (1)
- apoptosis (1)
- betaglycan (1)
- biocompatibility (1)
- biocompatible materials (1)
- bioconjugation (1)
- biological models (1)
- bone critical size defect (1)
- bone marrow (1)
- bone morphogenetic protein (1)
- bone morphogenetic protein 2 (BMP2) (1)
- bone morphogenetic protein 9 (BMP9) (1)
- bone morphogenetic proteins (1)
- brachtydacyly type A2 (1)
- cartilage (1)
- cell binding (1)
- cell cycle and cell division (1)
- cell differentiation (1)
- cell metabolism (1)
- cell proliferation (1)
- chondrogenesis (1)
- chondrogenic hypertrophy (1)
- clinical applications (1)
- collagen sponge (1)
- coreceptor (1)
- covalent coupling (1)
- cross-talk (1)
- cryostructured scaffolds (1)
- crystal structure (1)
- crystal-structure (1)
- differentiation (1)
- dominant-negative mutatio (1)
- fibroblast growth factor (1)
- functional initiators (1)
- gene encoding noggin (1)
- glycoprotein (1)
- growth and differentiation factor 5 (1)
- heparin binding sites (1)
- inflammation (1)
- interface (1)
- inflammatory response (1)
- iron metabolism (1)
- ligand binding (1)
- ligand-receptor complex (1)
- ligand-receptor promiscuity (1)
- membrane receptor signaling (1)
- mesenchymal stromal cell (1)
- metallo-supramolecular polymer (1)
- molecular mechanism (1)
- morphogenetic protein receptors (1)
- mutagenesis (1)
- necrotic cell death (1)
- osteochondral lesion (1)
- platelet-derived growth factor (1)
- polymerization (1)
- polypeptoids (1)
- postpolymerization modification (1)
- proteins (1)
- receptor type III (1)
- regenerative medicine (1)
- rhBMP–2 (1)
- ring-opening polymerization (1)
- signal integration (1)
- signal specification (1)
- signal tranduction (1)
- signal transduction (1)
- signaling (1)
- superfamily (1)
- translational research (1)
- weight-bearing (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (19)
- Julius-von-Sachs-Institut für Biowissenschaften (6)
- Theodor-Boveri-Institut für Biowissenschaften (4)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (3)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (3)
- Institut für Funktionsmaterialien und Biofabrikation (2)
- Institut für Organische Chemie (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Augenklinik und Poliklinik (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 607051 (3)
- 242175-VascuBone (1)
- 242175‐VascuBone (1)
- 309962 (1)
- 723770 (1)
Purpose
Hypertrophic cartilage is an important characteristic of osteoarthritis and can often be found in patients suffering from osteoarthritis. Although the exact pathomechanism remains poorly understood, hypertrophic de-differentiation of chondrocytes also poses a major challenge in the cell-based repair of hyaline cartilage using mesenchymal stromal cells (MSCs). While different members of the transforming growth factor beta (TGF-β) family have been shown to promote chondrogenesis in MSCs, the transition into a hypertrophic phenotype remains a problem. To further examine this topic we compared the effects of the transcription growth and differentiation factor 5 (GDF-5) and the mutant R57A on in vitro chondrogenesis in MSCs.
Methods
Bone marrow-derived MSCs (BMSCs) were placed in pellet culture and in-cubated in chondrogenic differentiation medium containing R57A, GDF-5 and TGF-ß1 for 21 days. Chondrogenesis was examined histologically, immunohistochemically, through biochemical assays and by RT-qPCR regarding the expression of chondrogenic marker genes.
Results
Treatment of BMSCs with R57A led to a dose dependent induction of chondrogenesis in BMSCs. Biochemical assays also showed an elevated glycosaminoglycan (GAG) content and expression of chondrogenic marker genes in corresponding pellets. While treatment with R57A led to superior chondrogenic differentiation compared to treatment with the GDF-5 wild type and similar levels compared to incubation with TGF-ß1, levels of chondrogenic hypertrophy were lower after induction with R57A and the GDF-5 wild type.
Conclusions
R57A is a stronger inducer of chondrogenesis in BMSCs than the GDF-5 wild type while leading to lower levels of chondrogenic hypertrophy in comparison with TGF-ß1.